Fryer R M, Hsu A K, Eells J T, Nagase H, Gross G J
Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA.
Circ Res. 1999 Apr 16;84(7):846-51. doi: 10.1161/01.res.84.7.846.
Opioids have been previously shown to confer short-term cardioprotection against a prolonged ischemic insult. Therefore, the present study was designed to determine whether opioids can induce a delayed or "second window" of cardioprotection and to assess the potential involvement of the mitochondrial KATP channel. All rats were subjected to 30 minutes of ischemia and 2 hours of reperfusion (I/R). Control animals, injected with saline 24 hours before I/R, elicited an infarct size/area at risk (IS/AAR) of 62.9+/-3.4. TAN-67, a delta1-opioid receptor agonist, was administered 10 or 30 mg/kg IP 12, 24, 48, or 72 hours before I/R. TAN-67 (10 mg/kg) 12- or 24-hour pretreatment did not significantly reduce IS/AAR (62.1+/-6.3 and 43.3+/-7.3, respectively). Similarly, 12-hour pretreatment with TAN-67 (30 mg/kg) did not reduce IS/AAR (60.0+/-5.6); however, 24-hour pretreatment significantly reduced IS/AAR (34.5+/-5.9). Forty-eight-hour pretreatment with TAN-67 maximally reduced IS/AAR (29.2+/-7.0), and opioid-induced cardioprotection was lost after 72-hour pretreatment (61.7+/-3.8). TAN-67-induced cardioprotection could be abolished by pretreatment with the selective delta1-opioid receptor antagonist 7-benzylidenenaltrexone, BNTX, administered either 30 minutes before TAN-67 given 48 hours before I/R or 10 minutes before I/R in rats previously treated for 48 hours with TAN-67 (59.6+/-3.1 and 58.7+/-3.5, respectively). The involvement of the KATP channel was investigated with 2 inhibitors: glibenclamide, a nonselective KATP channel inhibitor, and 5-hydroxydecanoic acid, selective for the mitochondrial KATP channel in rabbits. Glibenclamide, administered 30 minutes before I/R in 48-hour TAN-67-pretreated rats, completely abolished cardioprotection (60. 4+/-3.2). Similarly, 5-hydroxydecanoic acid, administered 5 minutes before I/R in rats pretreated 48 hours previously with TAN-67, completely abolished cardioprotection (57.8+/-2.5). These results suggest that delta1-opioid receptor stimulation, 24 to 48 hours before an ischemic insult, produces a delayed cardioprotective effect that is possibly the result of mitochondrial KATP channel activation.
先前的研究表明,阿片类药物可对延长的缺血性损伤提供短期心脏保护作用。因此,本研究旨在确定阿片类药物是否能诱导延迟性或“第二窗口”心脏保护作用,并评估线粒体ATP敏感性钾通道(mitochondrial KATP channel)的潜在参与情况。所有大鼠均经历30分钟的缺血和2小时的再灌注(I/R)。在I/R前24小时注射生理盐水的对照动物,其梗死面积与危险面积之比(IS/AAR)为62.9±3.4。在I/R前12、24、48或72小时,腹腔注射给予δ1阿片受体激动剂TAN-67,剂量为10或30mg/kg。TAN-67(10mg/kg)在12小时或24小时预处理时,并未显著降低IS/AAR(分别为62.1±6.3和43.3±7.3)。同样,TAN-67(30mg/kg)12小时预处理也未降低IS/AAR(60.0±5.6);然而,24小时预处理显著降低了IS/AAR(34.5±5.9)。TAN-67 48小时预处理最大程度地降低了IS/AAR(29.2±7.0),而72小时预处理后阿片类药物诱导的心脏保护作用消失(61.7±3.8)。TAN-67诱导的心脏保护作用可被选择性δ1阿片受体拮抗剂7-苄叉基纳曲酮(BNTX)预处理所消除,在I/R前48小时给予TAN-67前30分钟或在先前用TAN-67处理48小时的大鼠I/R前10分钟给予BNTX(分别为59.6±3.1和58.7±3.5)。使用两种抑制剂研究了KATP通道的参与情况:格列本脲,一种非选择性KATP通道抑制剂;以及5-羟基癸酸,对兔线粒体KATP通道具有选择性。在48小时TAN-67预处理的大鼠I/R前30分钟给予格列本脲,完全消除了心脏保护作用(60.4±3.2)。同样,在先前用TAN-67预处理48小时的大鼠I/R前5分钟给予5-羟基癸酸,也完全消除了心脏保护作用(57.8±2.5)。这些结果表明,在缺血性损伤前24至48小时刺激δ1阿片受体,可产生延迟性心脏保护作用,这可能是线粒体KATP通道激活的结果。